# Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

> **NCT00087126** · PHASE2 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 27 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** topotecan hydrochloride

## Key facts

- **NCT ID:** NCT00087126
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2010-01
- **Final completion:** —
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00087126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00087126, "Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00087126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*